Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
- 99.2 Kamada LTD'S Consolidated Financial Statements As of September 30, 2022 (Unaudited)
- Download Excel data file
- View Excel data file
KMDA similar filings
- 4 Jan 23 Kamada Announces Submission of Application to the U.S. FDA to Manufacture CYTOGAM® at the Company’s Facility in Israel
- 22 Dec 22 Report of Foreign Private Issuer
- 19 Dec 22 Kamada Announces Planned Transition of Chief Financial Officer
- 22 Nov 22 Kamada Reports Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
- 17 Nov 22 Current report (foreign) (amended)
- 16 Nov 22 Report of Foreign Private Issuer
- 8 Nov 22 Notice of Annual General Meeting of Shareholders
Filing view
External links